Drug Shortage Report for CISPLATIN INJECTION, BP
Report ID | 3275 |
Drug Identification Number | 02355183 |
Brand name | CISPLATIN INJECTION, BP |
Common or Proper name | CISPLATIN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | CISPLATIN |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 100 ML VIAL OF 100 MG | FLACON DE 100 ML DE 100 MG |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-03-06 |
Actual start date | 2017-03-06 |
Estimated end date | 2017-04-12 |
Actual end date | 2017-03-30 |
Shortage status | Resolved |
Updated date | 2017-04-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-04-06 | English | Compare |
v4 | 2017-03-17 | French | Compare |
v3 | 2017-03-17 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v1 | 2017-03-17 | English | Compare |
Showing 1 to 5 of 5